GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GSK GlaxoSmithKline PLC

Pre-Mkt 04-25 07:24:40 EDT

37.50

+0.47

+1.27%

盘前37.23

-0.27-0.72%

07:17 EDT

High37.51	Low36.84	Vol4.77M
Open37.04	D1 Closing37.03	Amplitude1.82%
Mkt Cap75.97B	Tradable Cap73.46B	Total Shares2.03B
T/O177.58M	T/O Rate0.24%	Tradable Shares1.96B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"GSK","market":"US","secType":"STK","nameCN":"GlaxoSmithKline PLC","latestPrice":37.5,"timestamp":1745524800000,"preClose":37.03,"halted":0,"volume":4765088,"hourTrading":{"tag":"盘前","latestPrice":37.23,"preClose":37.5,"latestTime":"07:17 EDT","volume":6718,"amount":250584.44325399998,"timestamp":1745579844402},"delay":0,"floatShares":1958899252,"shares":2025974612,"eps":1.557394,"marketStatus":"Pre-Mkt","change":0.47,"latestTime":"04-25 07:24:40 EDT","open":37.04,"high":37.51,"low":36.835,"amount":177576398.399616,"amplitude":0.018228,"askPrice":37.28,"askSize":2400,"bidPrice":37.25,"bidSize":1300,"shortable":3,"etf":0,"ttmEps":1.557394,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745587800000},"marketStatusCode":1,"adr":1,"adrRate":2,"listingDate":977893200000,"exchange":"NYSE","adjPreClose":37.5,"dividendRate":0.043266,"preHourTrading":{"tag":"盘前","latestPrice":37.23,"preClose":37.5,"latestTime":"07:17 EDT","volume":6718,"amount":250584.44325399998,"timestamp":1745579844402},"postHourTrading":{"tag":"盘后","latestPrice":37.31,"preClose":37.5,"latestTime":"17:01 EDT","volume":53918,"amount":2021899.3801,"timestamp":1745528512865},"volumeRatio":0.932156971037545,"impliedVol":0.3079,"impliedVolPercentile":0.8233},"requestUrl":"/m/hq/s/GSK/tweets","defaultTab":"tweets","newsList":[{"id":"2529663464","title":"Shingles Vaccine Appears to Lower Dementia Risk -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2529663464","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529663464?lang=en_us&edition=full_marsco","pubTime":"2025-04-24 04:40","pubTimestamp":1745440800,"startTime":"0","endTime":"0","summary":"Mounting evidence suggests that vaccination against the varicella zoster virus -- which causes chickenpox in children and triggers shingles in adults -- also protects the brain.Several recent studies suggest that the vaccines reduce the risk of dementia in older adults, but key questions remain, including: How the vaccines might work to stop or delay the condition, and whether the benefit is limited to people of a certain age.The vaccines studied, Zostavax and Shingrix, both appeared to offer protection.The latest study found that among 70- and 80-year-olds in Australia, people who were eligible to get the Zostavax shot were 1.8 percentage points less likely to get a dementia diagnosis in the next 7.4 years than those who were ineligible. The study was published in the journal JAMA Wednesday.Many countries, including the U.S., have replaced Zostavax, which contains a live, weakened version of the varicella zoster virus, with a newer vaccine called Shingrix. Shingrix, approved in the U.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","GSK","BK4532","GSK.UK","BK4585","BK4007","BK4588"],"gpt_icon":0},{"id":"2529748654","title":"Why vaccine makers aren't worried about Trump administration cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=2529748654","media":"Yahoo Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529748654?lang=en_us&edition=full_marsco","pubTime":"2025-04-24 02:50","pubTimestamp":1745434227,"startTime":"0","endTime":"0","summary":"Large and mid-cap vaccine makers are, as of now, unworried about their 2025 pipelines in the face of research funding declines by the Trump administration and a drop in biotech funding.That's what some of the top vaccine-maker executives told Yahoo Finance this week at the World Vaccine Congress in Washington, D.C.These executives believe there will be no impact from the funding cuts and policies coming down from the Trump administration, while others view it as a four-year storm they will just have to weather before being able to carry on as usual afterward.\"We're in this for the long game. We believe in vaccines, in the value of vaccines, and what they bring to public health. Infectious diseases aren't going to go away, so the need for vaccines is going to remain long-term,\" said Sally Mossman, head of research portfolio strategy at Sanofi .It's no wonder since vaccines make up a good chunk of revenue, even for large-cap pharmaceuticals with diversified portfolios. Among the companie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-vaccine-makers-arent-worried-about-trump-administration-cuts-185027024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1061106388.HKD","LU1066051498.USD","SNY","LU1057294990.SGD","LU0203345920.USD","BK4581","LU2361044949.HKD","IE00B19Z3581.USD","LU0058720904.USD","IE0002270589.USD","GSK.UK","IE000M9KFDE8.USD","LU0321505868.SGD","LU0965508806.USD","LU1069347547.HKD","LU0861579265.USD","LU1934455277.USD","SG9999001176.USD","LU1883839398.USD","BK4568","MRK","LU0265550359.USD","LU1093756168.USD","BK4550","LU1116320737.USD","MRNA","LU1989772840.SGD","LU1037948897.HKD","IE0009355771.USD","LU0985481810.HKD","SG9999002232.USD","LU2361045086.USD","LU0211331839.USD","LU1035773651.USD","PFE","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","LU1430594728.SGD","BK4534","LU1066053197.SGD","SG9999014567.USD","BK4599","LU2023250843.SGD","LU1934455863.HKD","IE00BLSP4452.SGD","BK4533","LU2361044865.SGD","LU2468319806.SGD","GSK","LU0106261372.USD"],"gpt_icon":1},{"id":"2529632289","title":"Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for","url":"https://stock-news.laohu8.com/highlight/detail?id=2529632289","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529632289?lang=en_us&edition=full_marsco","pubTime":"2025-04-23 22:01","pubTimestamp":1745416866,"startTime":"0","endTime":"0","summary":"The market expects GSK  to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 30. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.This drug developer is expected to post quarterly earnings of $1.08 per share in its upcoming report, which represents a year-over-year change of -0.9%.Revenues are expected to be $9.54 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/analysts-estimate-gsk-gsk-report-140106250.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NEO","GSK"],"gpt_icon":0},{"id":"2529674521","title":"GlaxoSmithKline (GSK) Gets a Hold from UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2529674521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529674521?lang=en_us&edition=full_marsco","pubTime":"2025-04-23 16:26","pubTimestamp":1745396780,"startTime":"0","endTime":"0","summary":"In a report released today, Jo Walton from UBS maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of p1,600.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-hold-from-ubs-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-hold-from-ubs-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4585","BK4588","BK4007","LU1829250122.USD","BK4532","GSK.UK"],"gpt_icon":0},{"id":"2529499435","title":"GSK Advances Share Buyback Program with Recent Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2529499435","media":"TIPRANKS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529499435?lang=en_us&edition=full_marsco","pubTime":"2025-04-23 14:16","pubTimestamp":1745389005,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK has announced the repurchase of 711,400 of its ordinary shares as part of its ongoing bu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-share-buyback-program-with-recent-repurchase-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-share-buyback-program-with-recent-repurchase-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4585","GSK","GSK.UK","BK4007","LU1829250122.USD","BK4588"],"gpt_icon":0},{"id":"2529538885","title":"J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529538885","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529538885?lang=en_us&edition=full_marsco","pubTime":"2025-04-23 02:05","pubTimestamp":1745345112,"startTime":"0","endTime":"0","summary":"In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-sell-rating-for-glaxosmithkline-gsk-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-sell-rating-for-glaxosmithkline-gsk-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"gpt_icon":0},{"id":"2529539658","title":"GSK Rises Tuesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2529539658","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529539658?lang=en_us&edition=full_marsco","pubTime":"2025-04-23 00:06","pubTimestamp":1745337960,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares advanced 1.91% to GBP13.62 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index  rising 0.64% to 8,328.60.GSK PLC closed 25.31% below its 52-week high of GBP18.24, which the company reached on May 16th.Trading volume totaled 10.1 million, compared to the 50-day average of 10.8 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"gpt_icon":0},{"id":"2529587164","title":"Market Chatter: Trump Administration Mulls Cutting US Drug Prices to International Levels","url":"https://stock-news.laohu8.com/highlight/detail?id=2529587164","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529587164?lang=en_us&edition=full_marsco","pubTime":"2025-04-22 22:26","pubTimestamp":1745332000,"startTime":"0","endTime":"0","summary":"Drug companies were warned that the Trump administration is weighing linking US medicine prices to the lower amounts paid by other developed nations, Reuters reported Tuesday, citing two pharmaceutical company sources.The policy is expected to come from the agency that oversees Medicare and Medicaid, the report said.Price: 22.41, Change: +0.37, Percent Change: +1.67","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1267930490.SGD","LU2361044949.HKD","MRK","LU0965508806.USD","NVO","ABBV","IE0004445239.USD","LU0058720904.USD","JNJ","IE00BGHQF631.EUR","IE0002270589.USD","GSK.UK","LU2023251221.USD","IE00B19Z3581.USD","LU0170899867.USD","LU1430594728.SGD","IE00B42XCP33.USD","LU1066053197.SGD","LU0965509010.AUD","LU0943347566.SGD","LU1571399168.USD","LU0792757196.USD","LU1059921491.USD","LU0965509283.SGD","IE0034235303.USD","LU1732799900.SGD","LU1989771016.USD","GSK","LU1221951129.SGD","LU1323610961.USD","BK4566","LU2129689431.USD","SNY","LU0203345920.USD","BMY","BK4592","AZN","LU1829250122.USD","LU2089284900.SGD","LU2237443895.HKD","LU1699723380.USD","NVS","LU1032466523.USD","LU2089283258.USD","PFE","LU0320765489.SGD","LU0795875086.SGD","LU2360032135.SGD","LU0265550946.USD","LU1883839398.USD"],"gpt_icon":1},{"id":"2529163587","title":"Trump Mulls Cutting US Drug Prices to International Levels, Reuters Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2529163587","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529163587?lang=en_us&edition=full_marsco","pubTime":"2025-04-22 22:21","pubTimestamp":1745331708,"startTime":"0","endTime":"0","summary":"Price: 22.38, Change: +0.34, Percent Change: +1.54","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2089284900.SGD","IE00B19Z3581.USD","LU1059921491.USD","LU1571399168.USD","LU2360032135.SGD","BK4592","IE00B42XCP33.USD","LU1430594728.SGD","LU0965509010.AUD","NVS","LU0058720904.USD","LU1221951129.SGD","LU1066053197.SGD","IE0034235303.USD","LU1883839398.USD","GSK","JNJ","LU1032466523.USD","LU2237443895.HKD","LU0320765489.SGD","LU0943347566.SGD","BK4566","ABBV","LU1989771016.USD","BMY","LU1732799900.SGD","IE0002270589.USD","LU0965509283.SGD","AZN","IE00BGHQF631.EUR","LU0795875086.SGD","LU0170899867.USD","LU2089283258.USD","IE0004445239.USD","MRK","LU2361044949.HKD","LU2023251221.USD","LU0965508806.USD","LU1829250122.USD","LU0792757196.USD","LU0265550946.USD","LU2129689431.USD","LU1323610961.USD","GSK.UK","PFE","LU1699723380.USD","LU1267930490.SGD","SNY","LU0203345920.USD"],"gpt_icon":0},{"id":"2529331314","title":"GSK Enhances Shareholder Value with Strategic Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2529331314","media":"TIPRANKS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529331314?lang=en_us&edition=full_marsco","pubTime":"2025-04-22 14:16","pubTimestamp":1745302595,"startTime":"0","endTime":"0","summary":"An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK plc announced the purchase of 684,200 of its own ordinary shares as part of its ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-enhances-shareholder-value-with-strategic-buyback-15?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-enhances-shareholder-value-with-strategic-buyback-15?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4007","GSK","LU1829250122.USD","BK4585","BK4588","BK4532"],"gpt_icon":0},{"id":"2529113351","title":"Top Research Reports for Visa, ServiceNow & Progressive","url":"https://stock-news.laohu8.com/highlight/detail?id=2529113351","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529113351?lang=en_us&edition=full_marsco","pubTime":"2025-04-22 04:49","pubTimestamp":1745268540,"startTime":"0","endTime":"0","summary":"Monday, April 21, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-research-reports-visa-servicenow-204900265.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1430594728.SGD","ACV","LU0731783048.USD","PLAY","CWCO","LU1366333091.USD","LU0316494557.USD","LU0011850046.USD","LU1235295455.SGD","BK4216","MCEM","LU2023250843.SGD","LU0342679015.USD","LU0289961442.SGD","LU1261432733.SGD","LU1481011911.USD","LU1983260115.SGD","LU0642271901.SGD","LU2272731865.HKD","IE00BKVL7J92.USD","NOW","LU0109391861.USD","LU1923622291.USD","PRPO","AMED","SG9999011175.SGD","LU1551013342.USD","BMI","PAYX","LU1169589451.USD","GSK","GSK.UK","BK4581","LU0545562505.USD","LU1815336760.USD","LUV","TM","LU1116320737.USD","PGR","IE00BMPRXN33.USD","AEO","SGXZ81514606.USD","V","03160","LU0772969993.USD","LU1228905037.USD","BK4585","CACC","IE00BMPRXR70.SGD"],"gpt_icon":1},{"id":"2528135727","title":"GSK Says Health Canada Approves Expanded Jemperli Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2528135727","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528135727?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 02:51","pubTimestamp":1744915894,"startTime":"0","endTime":"0","summary":"GSK (GSK) said Thursday Health Canada has approved Jemperli for use in combination with chemotherapy to treat adults with primary advanced or first recurrent endometrial cancer.The approval broadens t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1829250122.USD","GSK.UK","BK4585","BK4588","BK4532","GSK","BK4007"],"gpt_icon":0},{"id":"2528722724","title":"GSK Pharma put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2528722724","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528722724?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 01:55","pubTimestamp":1744912513,"startTime":"0","endTime":"0","summary":"Bearish flow noted in GSK (GSK) Pharma with 3,615 puts trading, or 1.6x expected. Most active are May-25 30 puts and Aug-25 35 puts, with total vol...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-pharma-put-volume-heavy-and-directionally-bearish-23?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-pharma-put-volume-heavy-and-directionally-bearish-23?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4532","GSK","LU1829250122.USD","BK4585","BK4007","BK4588"],"gpt_icon":0},{"id":"2528761728","title":"GSK Gets UK Approval for Blenrep Combinations in Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2528761728","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528761728?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 00:04","pubTimestamp":1744905889,"startTime":"0","endTime":"0","summary":"GSK  said Thursday the UK's Medicines and Healthcare products Regulatory Agency has authorized the use of Blenrep combinations to treat relapsed or refractory multiple myeloma.Blenrep is now approved for the treatment of adults with multiple myeloma in combination with bortezomib and dexamethasone in patients who have received at least one prior therapy, GSK said.The regulator also approved the drug in combination with pomalidomide and dexamethasone in patients who have received at least one prior therapy, including lenalidomide, it added.This authorization marks the first in the world for Blenrep in this treatment setting, the company said.Price: 35.76, Change: +0.39, Percent Change: +1.09","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK.UK","BK4588","BK4532","LU1829250122.USD","GSK","BK4007","BK4585"],"gpt_icon":0},{"id":"2528286057","title":"Alector Completes Enrollment for Phase 2 Alzheimer's Trial of AL101","url":"https://stock-news.laohu8.com/highlight/detail?id=2528286057","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528286057?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 00:01","pubTimestamp":1744905676,"startTime":"0","endTime":"0","summary":"Alector (ALEC) said Thursday it has completed enrollment for PROGRESS-AD, a 76-week phase 2 trial assessing the safety and effectiveness of AL101/GSK4527226 in slowing early-stage Alzheimer's disease ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4588","BK4007","LU1829250122.USD","BK4585","GSK.UK","ALEC","GSK","BK4532"],"gpt_icon":0},{"id":"2528769747","title":"GSK reports Blenrep combinations approved by MHRA","url":"https://stock-news.laohu8.com/highlight/detail?id=2528769747","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528769747?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 23:20","pubTimestamp":1744903223,"startTime":"0","endTime":"0","summary":"GSK (GSK) plc announced the authorization of Blenrep by the Medicines and Healthcare products Regulatory Agency. “In the UK, Blenrep is approved fo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-reports-blenrep-combinations-approved-by-mhra?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-reports-blenrep-combinations-approved-by-mhra?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU1829250122.USD","GSK","GSK.UK","BK4585","BK4532","BK4588"],"gpt_icon":0},{"id":"2528742231","title":"GSK’s Blenrep Combinations Approved in UK for Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2528742231","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528742231?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 23:17","pubTimestamp":1744903079,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK has announced the UK MHRA’s approval of Blenrep combinations for treating relapsed/...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-blenrep-combinations-approved-in-uk-for-multiple-myeloma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-blenrep-combinations-approved-in-uk-for-multiple-myeloma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4588","BK4532","LU1829250122.USD","GSK","BK4007","BK4585"],"gpt_icon":0},{"id":"2528741330","title":"GSK Executives Increase Share Interests Following Dividend Reinvestment","url":"https://stock-news.laohu8.com/highlight/detail?id=2528741330","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528741330?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 22:32","pubTimestamp":1744900362,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK plc has announced an increase in notional interest in its ordinary shares for sever...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-increase-share-interests-following-dividend-reinvestment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-increase-share-interests-following-dividend-reinvestment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4007","LU1829250122.USD","BK4532","BK4588","BK4585","GSK.UK"],"gpt_icon":0},{"id":"2528209335","title":"GSK Says CDC Panel Recommends Penmenvy for Adolescent Meningococcal Vaccination","url":"https://stock-news.laohu8.com/highlight/detail?id=2528209335","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528209335?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 05:41","pubTimestamp":1744839660,"startTime":"0","endTime":"0","summary":"GSK said a Centers for Disease Control and Prevention advisory board called for its drug Penmenvy to be part of the adolescent meningococcal vaccination schedule.Penmenvy was recommended to help protect people who are more than 10 years old against disease-causing serogroups of Neisseria meningitidis, as an alternative to the administration of several separate vaccinations, GSK said Wednesday. The recommendation will be reviewed and if adopted would allow for vaccination in fewer doses, which may simplify delivery and improve immunization rates, GSK added.In February, the Food and Drug Administration approved the company's MenABCWY vaccine for use in individuals aged 10 through 25 years.Vaccine doses will be ready for use in the U.S. in summer, GSK said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","BK4007","GSK","LU1829250122.USD","BK4585","BK4532","BK4588","CDC"],"gpt_icon":0},{"id":"2528094272","title":"GSK ‘pleased’ ACIP voted in favor of using RSV vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2528094272","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528094272?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 05:40","pubTimestamp":1744839610,"startTime":"0","endTime":"0","summary":"GSK (GSK) said it is “pleased” that the Advisory Committee on Immunization Practices voted in favor of recommending the use of RSV vaccines includi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-pleased-acip-voted-in-favor-of-using-rsv-vaccines?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-pleased-acip-voted-in-favor-of-using-rsv-vaccines?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK.UK","BK4585","BK4588","BK4532","GSK","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":0.0437},{"period":"1month","weight":-0.028},{"period":"3month","weight":0.0943},{"period":"6month","weight":-0.0005},{"period":"1year","weight":-0.0822},{"period":"ytd","weight":0.1088}],"compareEarnings":[{"period":"1week","weight":0.0385},{"period":"1month","weight":-0.05},{"period":"3month","weight":-0.1008},{"period":"6month","weight":-0.0559},{"period":"1year","weight":0.0817},{"period":"ytd","weight":-0.0672}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.577778,"avgChangeRate":0.012956},{"month":2,"riseRate":0.466667,"avgChangeRate":-0.001972},{"month":3,"riseRate":0.622222,"avgChangeRate":0.021018},{"month":4,"riseRate":0.652174,"avgChangeRate":0.031314},{"month":5,"riseRate":0.4,"avgChangeRate":-0.008934},{"month":6,"riseRate":0.6,"avgChangeRate":0.011286},{"month":7,"riseRate":0.555556,"avgChangeRate":0.004756},{"month":8,"riseRate":0.577778,"avgChangeRate":0.004428},{"month":9,"riseRate":0.511111,"avgChangeRate":0.004151},{"month":10,"riseRate":0.511111,"avgChangeRate":0.011448},{"month":11,"riseRate":0.466667,"avgChangeRate":0.009663},{"month":12,"riseRate":0.6,"avgChangeRate":0.013955}],"exchange":"NYSE","name":"GlaxoSmithKline PLC","nameEN":"GlaxoSmithKline PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GlaxoSmithKline PLC,GSK,GlaxoSmithKline PLC股票,GlaxoSmithKline PLC股票老虎,GlaxoSmithKline PLC股票老虎国际,GlaxoSmithKline PLC行情,GlaxoSmithKline PLC股票行情,GlaxoSmithKline PLC股价,GlaxoSmithKline PLC股市,GlaxoSmithKline PLC股票价格,GlaxoSmithKline PLC股票交易,GlaxoSmithKline PLC股票购买,GlaxoSmithKline PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction